NCT06718907 Mitigating Response to Stressors in Pregnant Women
| NCT ID | NCT06718907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nova Southeastern University |
| Condition | Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-12-20 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-12-20 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stress-induced pregnancy complications are significant contributors to preterm labor as well as maternal and perinatal morbidity and mortality. The goals of this study are two folds: first it aims to capture the pregnant woman's journey to seek and receive prenatal care. Second, this study aims to develop models that 1) assess the adverse health and biological effects of social factors on pregnant women who experience repeated or chronic stress, 2) address how stress can be mitigated in pregnant women from different backgrounds who experience high stress.
Eligibility Criteria
Inclusion Criteria: in 24 weeks gestation or more * between 21 and 37 years of age Exclusion Criteria: * in less than 24 weeks gestation * high risk pregnancies
Contact & Investigator
Gesulla Cavanaugh, PhD, MPH, MS
PRINCIPAL INVESTIGATOR
Nova Southeastern University
Frequently Asked Questions
Who can join the NCT06718907 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 37 Years, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06718907 currently recruiting?
Yes, NCT06718907 is actively recruiting participants. Contact the research team at gcavanaugh@nova.edu for enrollment information.
Where is the NCT06718907 trial being conducted?
This trial is being conducted at Davie, United States.
Who is sponsoring the NCT06718907 clinical trial?
NCT06718907 is sponsored by Nova Southeastern University. The principal investigator is Gesulla Cavanaugh, PhD, MPH, MS at Nova Southeastern University. The trial plans to enroll 50 participants.